GlassScriptPhysician profile
Nima Naghshineh
NPI 1316103799
$120,814.43
in general payments reported to CMS, 2019-2025
8 companies · $31K in 2025
The $31K reported for 2025 was more than what 97% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.94 · 2020: $117 · 2021: $10K · 2022: $14K · 2023: $46K · 2024: $19K · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $89K · Travel and Lodging: $4,929 · Food and Beverage: $1,722 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $675 · Long Term Medical Supply Or Device Loan: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $88,652.50 |
| Travel and Lodging | $4,928.82 |
| Food and Beverage | $1,722.37 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $675.00 |
| Long Term Medical Supply Or Device Loan | $651.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $68,216.29 | 2023-2025 | |
| Abbvie INC. | $28,282.71 | 2022-2025 | |
| Allergan, INC. | $23,205.62 | 2020-2022 | |
| Integra Lifesciences Corporation | $670.17 | 2022-2025 | Durasorb Monofilament Mesh |
| Tela Bio, INC. | $296.69 | 2022-2024 | Ovitex 2s |
| Galderma Laboratories, L.P. | $69.40 | 2020-2023 | |
| Mentor Worldwide LLC | $43.61 | 2022-2025 | Mentor Cpx 2 Breast Tissue Expander, Mentor Memorygel Breast Implant, Mentor Memorygel Resterilizable Gel Sizer |
| Tepha INC | $29.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nima Naghshineh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.